Research Articles
The Precision Medicine Battle: Protecting Vulnerable Children from Fungal Invaders
How therapeutic drug monitoring is revolutionizing voriconazole treatment for children with cancer facing invasive fungal infections
Nature's Antiviral Arsenal: Indonesian Plants Against Hepatitis C
Discover how Indonesian medicinal plants from East Java show potent antiviral activity against Hepatitis C virus, bridging traditional medicine and modern virology.
Nature's Hidden Shield: How a Plant Compound Supercharges Your First Line of Defense
Discover how berberine hydrochloride enhances innate immunity through the p38 MAPK pathway to protect against pathogen infections.
The Hidden Battle: Hepatitis Viruses Among Ethiopia's Military Personnel
Investigating the prevalence and risk factors of hepatitis B and C viruses among Ethiopian military personnel at Bahir Dar Armed Forces General Hospital.
Unlocking the Secrets of Cryptosporidium: How a Tiny Protein Could Defeat a Global Killer
Discover how the gp40/15 protein complex in Cryptosporidium could lead to breakthrough treatments and vaccines against this deadly parasite.
Molecular Sabotage: How Stealthy Herpesviruses Disarm Our Immunity
Exploring how HHV-6 and HHV-7 manipulate CD4+ T cells to compromise immune function through sophisticated molecular mechanisms.
The Silent Link: How HIV Affects the Brain's Blood Vessels
Exploring the pathomechanisms of HIV-associated cerebral small vessel disease and its impact on brain health
The Great Blood Cell Mystery: A Lupus Detective Story
Exploring the unusual case of thrombocytopenia in SLE patients and the diagnostic journey from ITP to TTP
Disarming a Superbug: How a Tiny Molecule Could Revolutionize Pseudomonas aeruginosa Treatment
Explore how phenylalanine arginyl β-naphthylamide (PAβN) affects imipenem resistance and virulence in Pseudomonas aeruginosa through dual-action mechanisms.
Hope for Aching Joints: How a Targeted Therapy Fights Psoriatic Arthritis
Explore how etanercept, a targeted biologic therapy, offers new hope for patients with treatment-resistant psoriatic arthritis through a 26-week clinical study.